BBOT Forecast — Price Prediction for 2025. Should I Buy BBOT?
1-Day-Price-Prediction
+0.56%
1-Week Prediction
+0.31%
1-Month Prediction
+1.19%
2026 Prediction
-100%
2030 Prediction
-100%
Based on our advanced algorithm, we predict that BBOT stock price will experience significant movement in the coming periods. Our 1-day prediction estimates a price of $11.92, while the 1-week outlook suggests a value of $11.89. For the 1-month forecast, we project a price of $11.99. Looking further ahead, our 2026 projection estimates a value of $0.00, with a long-term 2030 forecast reaching $0.00. Stay informed and make strategic decisions with our data-driven insights!
Should I Buy BridgeBio Oncology Therapeutics Inc Stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. BBOT has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
BBOT stock price ended at $11.92 on Wednesday, after rising0.59%
The BridgeBio Oncology Therapeutics Inc stock price increased by 0.59% on the last trading day (17 Dec 2025), rising from 11.94 to 11.85. Throughout the last trading session, the stock experienced a fluctuation of 6.21% , ranging from a day low of $11.75 to a day high of 12.48. The price has declined in 7 of the last 10 days, resulting in a total change of 4.41% during this period. On the last day, trading volume decrease by 16.08K shares, with the rising prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 140.32K shares were traded, amounting to approximately 1.70M.
BBOT Technical Signals
BBOT(BridgeBio Oncology Therapeutics Inc Corp) has 2 buy signals and 3 sell signals now. The current trend is a downtrend starting from 2025-12-11. The total price change during this trend is -7.17%. Recently, the price has increased while volume droped, indicating a potential warning signal. The average turnover of BBOT over the last 5 trading days is 1.15M. Overall, the technical indicator signals lean more toward a Neutral outlook in the mid-term.
BBOT Moving Average Analysis
BridgeBio Oncology Therapeutics Inc's overall moving average trend leans more bearish as of Wednesday, December 17, 2025, with 2 negative signals and 2 positive signal. In the mid-term, the SMA_20 being above the SMA_60 signals a strong bullish trend. There will be some resistance from the lines at $15.18, and $16.65. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $10.42, and $8.95. A break-down below any of these levels will issue sell signals.
BBOT Short Selling Analysis
The short sale ratio of BridgeBio Oncology Therapeutics Inc(BBOT) as of 10 Dec 2025 is 29.48%, rising from last trading day. With increasing price from 12.53 to 12.88. The short sell activity indicate that short sellers may be anticipating a price reversion.
Technical Signal
Technical Signals Summary
Sell
3
Buy
2
Moving Average
Swing
Negative
Stock Price Below SMA_5
Short Term
Negative
SMA_5 Below SMA_20
Mid Term
Positive
SMA_20 Above SMA_60
Long Term
Positive
SMA_60 Above SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
2 Bullish Signals
2 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Indicators
Signal
Value
Meaning
Momentum (10 days)
MOM_10 > 0
0.85
Bullish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 > 0
0.0118
Bullish
3 Bearish Signals
3 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
Indicators
Signal
Value
Meaning
Indicators
Signal
Value
Meaning
Awesome Oscillator (5, 34)
AO_5_34 < 0
-0.0845
Bearish
Moving Average
5-day SMA crosses below 10-day SMA
--
Bearish
Moving Average
5-day SMA crosses below 20-day SMA
--
Bearish
BBOT Stock Forecast
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
Month
Min. Price
Avg. Price
Max. Price
Potential ROI
In 2026, BridgeBio Oncology Therapeutics Inc (BBOT) is anticipated to change hands in a trading channel between $0.00 and $0.00.
BBOT Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to BridgeBio Oncology Therapeutics Inc(BBOT), our algorithm predicts BBOT's 1-month price at $12.56, with an -0.27%downwardshift. Using a similarity score up to 90.83%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for BridgeBio Oncology Therapeutics Inc (BBOT.O) stock, as of Sunday, December 14, 2025 , forecasts a -0.27% change over the next month, based on its high correlation with JCTC.O stock patterns. The similarity between their price movements over the analyzed periods is 90.83%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
BBOT
No data
JCTC
Down: -0.27%Similarity: 90.83%
Name
Similarity
Up/Down
JCTC.O
90.83%
-0.27%
BBOT Seasonality Analysis
Based on BBOT's historical stock price data across all years, the probability of a positive return in December is0.00%, suggesting it maynotbe an ideal month to invest in BBOT. In contrast,Septemberoffers the highest probability of positive returns at100.00%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying BridgeBio Oncology Therapeutics Inc (BBOT.O) stock in September has the highest probability of a positive return (100.00%), while January has the lowest probability (0.00%).
Performance Seasonality
The chart shows BridgeBio Oncology Therapeutics Inc. (BBOT)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
Should I buy BridgeBio Oncology Therapeutics Inc (BBOT.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. BBOT has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
Which months have the highest win rate for buying BridgeBio Oncology Therapeutics Inc (BBOT.O) stock in a year?
The radar chart shows that buying BridgeBio Oncology Therapeutics Inc (BBOT.O) stock in September has the highest probability of a positive return (100.00%), while January has the lowest probability (0.00%).
How has BridgeBio Oncology Therapeutics Inc. (BBOT)'s stock price performed over the past three years?
BBOT's stock price rose by 20.40% in 2025,in by in
Bearish technical signals of BBOT include: AO_5_34 < 0, 5-day SMA crosses below 10-day SMA, 5-day SMA crosses below 20-day SMA.
Is BBOT a buy based on overall technical signals summary?
BBOT has 2 buy signals and 3 sell signals now. Overall the technical rating for BBOT is Neutral . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of BBOT.
What is the trend of BridgeBio Oncology Therapeutics Inc (BBOT)'s moving average?
BridgeBio Oncology Therapeutics Inc's overall moving average trend leans more bearish as of December 17 2025, with 2 negative signals and 2 positive signal.
What is price prediction for BBOT stock next month?
The price prediction chart for BridgeBio Oncology Therapeutics Inc (BBOT.O) stock, as of December 14 2025, forecasts a -0.27% change over the next month, based on its high correlation with JCTC stock patterns. The similarity between their price movements over the analyzed periods is 90.83%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
Negative
Positive
